Wealth Effects of the Pharmaceutical Industry-Physician Interaction Compliance Guidelines on Large Pharmaceutical Companies
Year of publication: |
2014
|
---|---|
Authors: | Jambulingam, Thani |
Other Persons: | Sharma, Rajneesh (contributor) ; Ghani, WaQar (contributor) |
Publisher: |
[2014]: [S.l.] : SSRN |
Subject: | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Vermögenseffekt | Wealth effect |
Extent: | 1 Online-Ressource (48 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: International Journal of Pharmaceutical and Healthcare Marketing, Vol. 3, No. 3, pp. 210-235, 2009 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments May 11, 2009 erstellt |
Classification: | M31 - Marketing ; I11 - Analysis of Health Care Markets |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Relationship between the Number of Firms and Generic Drug Price Competition
Jambulingam, Thani, (2011)
-
Estimation of Promotional Strategies for Newer vs. Older Drugs Based On Physician Prescribing Data
Gönül, Füsun F., (2012)
-
Pioneering Advantage in Generic Drug Competition
Yu, Yu, (2014)
- More ...
-
Jambulingam, Thanigavelan, (2009)
-
Biotechnology Industry-Physician Interaction and OIG Guidelines : Evidence from the Stock Market
Jambulingam, Thani, (2014)
-
Jambulingam, Thani, (2009)
- More ...